ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,358,085 | +32.5% | 5,629,970 | +28.5% | 2.60% | +40.4% |
| Q2 2023 | $87,030,004 | +15.3% | 4,379,970 | -0.6% | 1.86% | -2.9% |
| Q1 2023 | $75,502,582 | +13.6% | 4,407,623 | +29.8% | 1.91% | +21.5% |
| Q4 2022 | $66,456,158 | +64.4% | 3,395,818 | +34.1% | 1.57% | +72.9% |
| Q3 2022 | $40,417,000 | +16.0% | 2,532,366 | 0.0% | 0.91% | +5.8% |
| Q2 2022 | $34,845,000 | +3.0% | 2,532,366 | +18.7% | 0.86% | +44.8% |
| Q1 2022 | $33,832,000 | -18.2% | 2,133,166 | +12.6% | 0.59% | +27.2% |
| Q4 2021 | $41,367,000 | -16.6% | 1,894,966 | +14.1% | 0.47% | -6.6% |
| Q3 2021 | $49,621,000 | +544.3% | 1,660,116 | +854.7% | 0.50% | +594.4% |
| Q2 2021 | $7,701,000 | – | 173,887 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |